IHC analysis (Figure 11A/Supplementary Figure S5A) revealed the level of infiltrating CD56+ cells (CD56 is not strictly specific for NK cells, but we estimated that CD56 gave a reasonable representation of NK cells in the tumor tissue [39]) was considerably higher in tumor tissues of mice treated with mAb04-MICA than tumors from mice treated with the same dose of mAb04. The gene discussed is NCAM1; the disease is neoplasm.